ARCHIVES

Aggressive, Tailored Therapy Improves Survival, Study Finds

This article is from The Cancer Letter archive.

Vol. 31 No. 10 | October 31, 2008

Download PDF Visit The Full Archive

Related Articles

In Brief: HHS Won’t Nominate Fischbach for NIH; Kirschstein in Charge

April 28, 2000

Denosumab Demonstrates Superiority Over Zometa For Bone Metastases

August 28, 2009

Mammography Panel Reaches Consensus On Most Issues

September 23, 1977

Senate Committee Passes Bill To Speed FDA Approval Of Follow-On Biologics.

June 29, 2007

Lasker Awards Announced

September 25, 2009

Glaxo, Mass General Begin Phase III Trial Of Tykerb

December 29, 2006